Clinical Trial Update: CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating CHOEP plus high-dose therapy and autologous stem cell transplant for T-cell non-Hodgkin lymphoma was terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Non-hodgkin Lymphoma

Drugs mentioned

• CHOEP (cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone/prednisolone)
• High-Dose Therapy + Auto SCT (high-dose chemotherapy followed by autologous stem cell transplant)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: T-cell Non-Hodgkin Lymphoma | Phase 2 | Status: TERMINATED | Results posted: 2017-01-11